Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida Paris

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Cancers|September 25, 2019
Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing PerspectivesLuisa Carbognin, Federica Miglietta, Ida Paris, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 2, 2023
Vasomotor symptoms and management of women undergoing treatment for breast cancer: literature review with focus on the therapeutic potential of cytoplasmic pollen extractStefano Lello, Ida Paris, Angelo Cagnacci, et al.
Recenti Progressi in Medicina|September 17, 2010
[Pharmacogenomics and chemotherapy]Ida Paris, Gian Carlo Antonini Cappellini, Paola Malaguti, et al.
Journal of Chemotherapy (Florence, Italy)|October 13, 2020
Exploring metastatic breast cancer treatment changes during COVID-19 pandemicPalma Fedele, Antonella Ferro, Valeria Sanna, et al.
Tumori|May 9, 2015
Widespread renal polycystosis induced by crizotinibMarco Di Girolamo, Ida Paris, Francesco Carbonetti, et al.
Human Genome Variation|May 16, 2018
Preliminary molecular evidence associating a novel BRCA1 synonymous variant with hereditary ovarian cancer syndromeAngelo Minucci, Paola Concolino, Maria De Bonis, et al.
Journal of Clinical Medicine|February 27, 2026
Modern Personalized Strategies for Breast Cancer Treatment: Bridging Precision Oncology and Psycho-OncologyGiuseppe Marano, Ida Paris, Gianandrea Traversi, et al.
Annals of Surgical Oncology|June 4, 2015
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control StudyMarco Petrillo, Ida Paris, Giuseppe Vizzielli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2017
Real-World Management of Trabectedin/Pegylated Liposomal Doxorubicin in Platinum-Sensitive Recurrent Ovarian Cancer Patients: A National SurveyGabriella Ferrandina, Giulia Amadio, Ida Paris, et al.
Cancers|May 23, 2020
Spectrum of Germline <i>BRCA1</i> and <i>BRCA2</i> Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of RomeConcetta Santonocito, Roberta Rizza, Ida Paris, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Cancers|September 25, 2019
Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing PerspectivesLuisa Carbognin, Federica Miglietta, Ida Paris, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 2, 2023
Vasomotor symptoms and management of women undergoing treatment for breast cancer: literature review with focus on the therapeutic potential of cytoplasmic pollen extractStefano Lello, Ida Paris, Angelo Cagnacci, et al.
Recenti Progressi in Medicina|September 17, 2010
[Pharmacogenomics and chemotherapy]Ida Paris, Gian Carlo Antonini Cappellini, Paola Malaguti, et al.
Journal of Chemotherapy (Florence, Italy)|October 13, 2020
Exploring metastatic breast cancer treatment changes during COVID-19 pandemicPalma Fedele, Antonella Ferro, Valeria Sanna, et al.
Tumori|May 9, 2015
Widespread renal polycystosis induced by crizotinibMarco Di Girolamo, Ida Paris, Francesco Carbonetti, et al.
Human Genome Variation|May 16, 2018
Preliminary molecular evidence associating a novel BRCA1 synonymous variant with hereditary ovarian cancer syndromeAngelo Minucci, Paola Concolino, Maria De Bonis, et al.
Journal of Clinical Medicine|February 27, 2026
Modern Personalized Strategies for Breast Cancer Treatment: Bridging Precision Oncology and Psycho-OncologyGiuseppe Marano, Ida Paris, Gianandrea Traversi, et al.
Annals of Surgical Oncology|June 4, 2015
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control StudyMarco Petrillo, Ida Paris, Giuseppe Vizzielli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2017
Real-World Management of Trabectedin/Pegylated Liposomal Doxorubicin in Platinum-Sensitive Recurrent Ovarian Cancer Patients: A National SurveyGabriella Ferrandina, Giulia Amadio, Ida Paris, et al.
Cancers|May 23, 2020
Spectrum of Germline <i>BRCA1</i> and <i>BRCA2</i> Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of RomeConcetta Santonocito, Roberta Rizza, Ida Paris, et al.
Pageof 10